antiviral drugs

FORMATION OF EXPERIENCE AGAINST THE CHALLENGES OF VIRAL INFECTION THROUGH THE USE OF STUDENTS KNOWLEDGE OF BIOSAFY TECHNOLOGIES, part 2

New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation – with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied.

FORMATION OF EXPERIENCE AGAINST THE CHALLENGES OF VIRAL INFECTION THROUGH THE USE OF STUDENTS KNOWLEDGE OF BIOSAFY TECHNOLOGIES, part 1

New challenges and the state of development of COVID-19 in connection with the spread of new strains of SARS-CoV-2 have been analyzed. Experience and knowledge in working with new means of protection of different types of vaccines are studied: both classic, based on inactivated virus or its fragment, and the new generation - with vector and genetic mRNA vaccines, as well as effective antiviral drugs. Biorisks and compliance with biosafety principles have been studied.

Preparedness for the challenges of viral infection and application of knowledge of biosafety technologies by students

The state of development of the disease on COVID-19 is analyzed, the need to comply with the principles of biosafety, competency base, which provide training for biotechnology and pharmaceuticals to create new effective drugs, including antiviral drugs, is emphasized. Introduction and deepening of knowledge of the principles of biosafety and biosecurity, the use of molecular PCR tests, serological ELISA tests, knowledge of the dangers of dual use of experimental studies affects almost all disciplines of "Biotechnology and Bioengineering" and "Pharmacy, Industrial Pharmacy".